Drug intelligence / Profile preview

danshitong capsule

Development stage: Unknown
Lead developer: Guangdong Wannianqing
Modality: Small Molecules
Administration: Oral

Overview

Danshitong Capsule is a proprietary Traditional Chinese Medicine (TCM) developed and manufactured by Wannianqing Pharmaceutical. It is primarily indicated for the treatment of gallstones (cholelithiasis) and cholecystitis. The formulation is composed of several herbal and mineral ingredients, including *Desmodium styracifolium*, *Artemisia capillaris*, and *Rheum palmatum*, which work synergistically to clear heat, promote diuresis, and stimulate gallbladder contraction to facilitate the expulsion of stones. It is an oral medication widely used in China for hepatobiliary disorders, particularly those characterized by damp-heat in the liver and gallbladder.

Brand names: Danshitong Capsules胆石通胶囊
Other names: Danshitong Jiaonang

Beyond the preview

Go deeper on danshitong capsule.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on danshitong capsule.

Explore the full profile